Tom Sellig, Adare Pharma Solutions, shares how the CDMO is positioning for growth amid US reshoring and oral dose innovation trends.
Tom Sellig
Advertisement
CEO, Adare Pharma Solutions
Articles by Tom Sellig
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5